DCF — CHI ST LUKES HEALTH BAYLOR MED CTR
Enterprise Value: $-1.7B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.7B
Enterprise Value
$-530.6M
PV of Cash Flows
$-1.1B
PV of Terminal Value
$-1.8B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-102.2M | -9.0% | $-150.2M | $-136.6M |
| Year 2 | $1.2B | $-93.5M | -8.0% | $-143.1M | $-118.2M |
| Year 3 | $1.2B | $-84.3M | -7.0% | $-135.3M | $-101.7M |
| Year 4 | $1.2B | $-80.6M | -6.0% | $-133.2M | $-90.9M |
| Year 5 | $1.3B | $-79.9M | -6.0% | $-134.0M | $-83.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.7B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09498051891289486
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5